These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 16166579)

  • 41. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC; Rabinstein AA
    Cerebrovasc Dis; 2012; 34(2):106-14. PubMed ID: 22868870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Telephonic guidance of systemic thrombolysis in acute ischemic stroke: safety outcome in rural hospitals.
    Vaishnav AG; Pettigrew LC; Ryan S
    Clin Neurol Neurosurg; 2008 May; 110(5):451-4. PubMed ID: 18353532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
    Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
    Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disappearing hyperdense middle cerebral artery sign is associated with striatocapsular infarcts on follow-up CT in ischemic stroke patients treated with intravenous thrombolysis.
    van Overbeek EC; Knottnerus IL; van Oostenbrugge RJ
    Cerebrovasc Dis; 2010 Aug; 30(3):285-9. PubMed ID: 20664262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging-based versus computed tomography-based thrombolysis in acute ischemic stroke: comparison of safety and efficacy within a cohort study.
    Gerischer LM; Fiebach JB; Scheitz JF; Audebert HJ; Endres M; Nolte CH
    Cerebrovasc Dis; 2013; 35(3):250-6. PubMed ID: 23548768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?
    Qureshi AI; Ezzeddine MA; Nasar A; Suri MF; Kirmani JF; Janjua N; Divani AA
    Neurology; 2006 Apr; 66(8):1171-4. PubMed ID: 16636232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
    Leiva-Salinas C; Patrie JT; Xin W; Michel P; Jovin T; Wintermark M
    Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial.
    Smith WS; Sung G; Starkman S; Saver JL; Kidwell CS; Gobin YP; Lutsep HL; Nesbit GM; Grobelny T; Rymer MM; Silverman IE; Higashida RT; Budzik RF; Marks MP;
    Stroke; 2005 Jul; 36(7):1432-8. PubMed ID: 15961709
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperdense sylvian fissure MCA "dot" sign: A CT marker of acute ischemia.
    Barber PA; Demchuk AM; Hudon ME; Pexman JH; Hill MD; Buchan AM
    Stroke; 2001 Jan; 32(1):84-8. PubMed ID: 11136919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute stroke: usefulness of early CT findings before thrombolytic therapy.
    von Kummer R; Allen KL; Holle R; Bozzao L; Bastianello S; Manelfe C; Bluhmki E; Ringleb P; Meier DH; Hacke W
    Radiology; 1997 Nov; 205(2):327-33. PubMed ID: 9356611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reliability of brain CT evaluation by stroke neurologists in telemedicine.
    Puetz V; Bodechtel U; Gerber JC; Dzialowski I; Kunz A; Wolz M; Hentschel H; Schultheiss T; Kepplinger J; Schneider H; Wiedemann B; Wojciechowski C; Reichmann H; Gahn G; von Kummer R
    Neurology; 2013 Jan; 80(4):332-8. PubMed ID: 23255831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Post rtPA CT brain may not be mandatory in all stroke patients when resources are limited.
    Dharmasaroja PA; Muengtaweepongsa S; Dharmasaroja P
    Clin Neurol Neurosurg; 2013 Mar; 115(3):285-8. PubMed ID: 22749008
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case-controlled comparison of thrombolysis outcomes between wake-up and known time of onset ischemic stroke patients.
    Manawadu D; Bodla S; Jarosz J; Keep J; Kalra L
    Stroke; 2013 Aug; 44(8):2226-31. PubMed ID: 23723307
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interobserver variation of ASPECTS in real time.
    Coutts SB; Demchuk AM; Barber PA; Hu WY; Simon JE; Buchan AM; Hill MD;
    Stroke; 2004 May; 35(5):e103-5. PubMed ID: 15073381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relation between reperfusion and hemorrhagic transformation in acute ischemic stroke.
    Horsch AD; Dankbaar JW; van der Graaf Y; Niesten JM; van Seeters T; van der Schaaf IC; Kappelle LJ; Velthuis BK;
    Neuroradiology; 2015 Dec; 57(12):1219-25. PubMed ID: 26337766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time dependence of reliability of noncontrast computed tomography in comparison to computed tomography angiography source image in acute ischemic stroke.
    Bal S; Bhatia R; Menon BK; Shobha N; Puetz V; Dzialowski I; Modi J; Goyal M; Hill MD; Smith EE; Demchuk AM
    Int J Stroke; 2015 Jan; 10(1):55-60. PubMed ID: 22974504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and validation of a simplified Stroke-Thrombolytic Predictive Instrument.
    Kent DM; Ruthazer R; Decker C; Jones PG; Saver JL; Bluhmki E; Spertus JA
    Neurology; 2015 Sep; 85(11):942-9. PubMed ID: 26291280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk rtPA: An iOS mobile application based on TURN for predicting 90-day outcome after IV thrombolysis.
    Asuzu D; NystrÓ§m K; Schindler J; Wira C; Greer D; Halliday J; Sheth KN
    Clin Neurol Neurosurg; 2016 Mar; 142():148-152. PubMed ID: 26875069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.